Open-Label, limited access protocol of Posaconazole in invasive fungal infections.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-003717-33-IT

Enrollment

Unknown

Registered

2007-01-19

Start date

2005-09-13

Completion date

Unknown

Last updated

2019-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Profilaxys of invasive mycotic infections in high risk neutropenic patients. MedDRA version: 6.1 Level: PT Classification code 10017533

Interventions

Trade Name: posaconazole Product Name: Posaconazole Product Code: SCH 56592 Pharmaceutical Form: Oral suspension Current Sponsor code: S

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026